• <strong id="aaqgw"></strong>
    <optgroup id="aaqgw"><object id="aaqgw"></object></optgroup>
    <strong id="aaqgw"><noscript id="aaqgw"></noscript></strong>
  • ABOUT US
    Pioneering Global Regenerative Science & Technology
    Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic rb-bFGF (FGF-2), having six commercialized biologics marketed in China since 1998. The products of the Company are principally prescribed for the treatment of wounds healing and diseases in Ophthalmology & Dermatology.
    More
    1
    Pioneer & Leader in Growth Factor
    1st global rb-bFGF drug — Beifuji

    1st global rb-bFGF eye drops — Beifushu
    2
    Solid APIs & R&D Capability
    Various proprietary APIs

    Diversified pipeline primarily in ophthalmology

    Honoured with the second prize of National Scientific and Technology Progress Award in 2004 and 2018
    3
    Entrenched Market Foothold
    9000 hospitals under sales & distribution coverage in China

    Market leader of growth factor drugs in Ophthalmology and Dermatology arena
    R&D
    Tomorrow's today
    4 In-house R&D platforms:

    · Growth Factor
    · Antibody
    · Drug Formulation
    · Blow-Fill-Seal (BFS)

    Leveraging on its in-house R&D platform,the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
    More
    R&D
    Tomorrow's today
    4 In-house R&D platforms:

    · Growth Factor
    · Antibody
    · Drug Formulation
    · Blow-Fill-Seal (BFS)

    Leveraging on its in-house R&D platform,the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
    More
    PRODUCTS
    Harnessing Innovations to Deliver Unmet Drugs for Blessing of People at Large
    We are dedicated to deliver products in Ophthalmology and Surgical arena, including three flagship product series: Beifushu, Beifuji and Beifuxin, which are prescribed for the treatment of wounds healing and diseases in Ophthalmology and Dermatology.
    Information is solely for medical professionals.
    Beifushu Eye Drops
    Beifushu is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd., the first domestic eye drops that can stimulate corneal reparation and improve healing quality of cornea.
    More
    Beifushu Eye Gel
    Beifushu eye gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Carbomer -a new generation of artificial tears, as a new matrix of the eye gel, can give patients a sustainable relief.

    With the effect of bFGF, Beifushu eye gel can stimulate corneal reparation and improve healing quality of cornea, keeping cornea in homeostasis.
    More
    Unit-dose Beifushu Eye Drops
    Single-dose Befushu eye drops is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. As the third generation of Beifushu Series, it is a preservative-free formulation potentially delivering best treatment outcomes to patients.
    More
    Beifuji Spray
    Beifuji  is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..

    The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
    More
    Beifuji Lyophilized Powder
    Beifuji Lyophilized Powder is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..

    The API of  Beifuji Lyophilized Powder is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
    More
    Beifuxin Gel
    Beifuxin gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd..

    The API of Beifuxin is recombinant bovine basic fibroblast growth factor (rb-bFGF) - a multifunctional growth factor with a wide range of bioactivity, which can stimulate the proliferation and differentiation of cells involved in wound healing
    More
    NEWS
    This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.
    AV无码AV在线A∨天堂,国产偷国产偷亚洲高清日韩,中文字幕永久免费,中文字幕91